We are delighted to announce the 5th Edition of India Vaccine Leaders Conclave 2026 which is going to be held in Pune during 20th & 21st August 2026, Hyatt, Pune. The IVLC strives to provide a meaningful theme of “India’s Bio-Ascent: Redefining Global Vaccine Value” & will assemble leading specialists from around the world including researchers, scientists, academicians, vaccinologists, immunologists, healthcare professionals, clinicians, government representatives & industry delegates who will share their knowledge on the field’s most recent ground-breaking advancements & discoveries & Collaborations. 

India's vaccine industry, the world's third largest by volume, is targeting over USD 3 billion in 2026, driven by biosimilars, government UIP expansions, and BioE3 policies boosting local production.

Globally, the market reaches USD 67-96 billion this year with 6-10% growth fuelled by mRNA vaccines for adults and pandemic readiness. Include AI-powered cold chains for better storage, faster manufacturing via PLI funds for APIs, and efforts to cut hesitancy through awareness and compensation schemes. Despite factory and regulatory hurdles, these steps position India as a key player amid rising demand for multi-disease shots.